麻豆传媒

ESC: Ticagrelor Fails to Improve on Clopidogrel After Switch

Single-center study contradicts PLATO in ACS patients

Aug 29, 2017

ESC: Huge Diet Study Shows Carbs, Not Fats Are the Problem

But PURE also challenges belief that more is better for fruits and vegetables

Aug 29, 2017

ESC: Merck REVEALS a Slightly Positive CETP Inhibitor Trial

A CETP inhibitor scores after 3 strikes for the class

Aug 29, 2017

ESC: Concomitant LAA Closure During Heart Surgery Scores a Win

But will making it routine safely prevent strokes?

Aug 28, 2017

ESC: A Second Opinion on NOACs in Stable CVD

Raymond Gibbons, MD, takes apart the COMPASS trial in favor of optimal medical therapy

Aug 28, 2017

ESC: No BP Spike Seen with Celecoxib Use

But ibuprofen boosts systolic pressure

Aug 28, 2017

ESC: Supplemental Oxygen Doesn't Save Lives in Suspected MI

Despite no harm in trial, 'it is clearly time for clinical practice to change'

Aug 28, 2017

ESC: Is Low BMI a Bigger Problem than Obesity After PCI?

Reverse J-curve seen for hospital stay, readmission, costs

Aug 27, 2017

ESC: NOAC Combo Tx Can Eliminate Need for Aspirin After PCI

Fewer bleeds and similar ischemic protection seen in RE-DUAL trial

Aug 27, 2017

Guns at Doors, But ESC Carries On

Barcelona meeting attracts 31,000

Aug 26, 2017

Inflammation, Secondary Prevention, Diet in Spotlight at ESC

CANTOS, COMPASS, PURE will headline the world's largest cardiology meeting

Aug 24, 2017

We Have Ruined Late-Breaking Clinical Trials in Cardiology

In this Revolution and Revelation, Milton Packer explains why a cornerstone of annual meetings has gone from sizzler to snoozer

Aug 23, 2017

Barcelona Attack Doesn't Derail ESC Plans

Cardiologists hang tough: 'If we change behavior, the terrorists have won'

Aug 18, 2017

CANTOS to Headline ESC

August's European Society of Cardiology meeting lineup released

Jun 22, 2017

ESC: Pope Backs Medical Research in Historic Speech

Addresses cardiology meeting in Rome

Aug 31, 2016

ESC: Medical Therapy Adequate for Plaque Erosion

Pilot study suggests stenting not needed in uncomplicated cases

Aug 31, 2016

ESC: Savaysa Safe for Afib Cardioversion

ENSURE-AF trial finds similarity to standard anticoagulant regimen

Aug 31, 2016

ESC: Winners Emerge in CAD Imaging Showdowns

Promising results for cardiac MRI, MPS, and PET

Aug 30, 2016

ESC: PCSK9 Tx -- Ready for Prime Time or Still Unproven?

Debate highlights pros and cons of these cholesterol-lowering drugs

Aug 30, 2016

ESC: NOAC Reversal Agent Effective in Study

But results may not sway FDA

Aug 30, 2016

ESC: DES or BMS? No Mortality Difference

After 6 years, death was as likely in DES patients as in BMS patients

Aug 30, 2016

ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

Aug 29, 2016

CardioBrief: Cardiologists Give SPRINT Thumbs Down

Trial should not be used in guidelines to lower blood pressure targets

Aug 29, 2016

ESC: Platelet Testing Still Doesn't Work in 2016

No clinical benefits observed even the elderly

Aug 28, 2016

ESC: CPAP Flops for Secondary CV Prevention

No impact on coronary, stroke risks from sleep apnea tx in SAVE trial

Aug 28, 2016

ESC: No Mortality Benefit With ICD in Nonischemic HF

Eleven fewer deaths over 5 years

Aug 28, 2016

ESC: Will CvLPRIT Change Practice?

BARCELONA -- Cardiologists react to findings from the CvLPRIT study, which challenge not only traditional thinking but also existing guidelines from both the U.S. and Europe, all of which say that treating nonculprit arteries in STEMI patients may be harmful.

Sep 03, 2014

ESC: Mixed Results with Steroids in TB Pericarditis

BARCELONA -- Adding steroids to anti-tuberculosis treatment for patients with tuberculous pericarditis can reduce the risk of complication and the resulting hospital admission, but adding prednisolone to tuberculosis treatment did not reduce the risk of death, researchers said here.

Sep 03, 2014

ESC: Xarelto Safe for Cardioverting Afib

BARCELONA -- Switching atrial fibrillation patients awaiting elective cardioversion to rivaroxaban (Xarelto) was as safe as warfarin in that setting.

Sep 02, 2014

ESC: Peto Analysis Called Short on Proof of Simvastatin/ Ezetimibe Cancer Safety

SEATTLE -- Simvastatin/ezetimibe (Vytorin) may increase the risk of cancer after all, concluded a leading American biostatistician who dismissed as prematurely reassuring an analysis by Richard Peto, Ph.D., F.R.S., that found the link with excess malignancy to be overblown.

Sep 04, 2008

ESC: In CABG versus Stent Trial, the Edge Goes to Bypass

MUNICH -- The latest round in the surgeons versus interventional cardiologists appears to have gone to the surgeons. So it would seem from today's roundtable discussion at the European Society of Cardiology meeting here.

Sep 01, 2008